For much of the past decade, the US nicotine and ENDS marketplace has operated in a state of...
3 minute read
Last week’s announcement from FDA regarding the authorization of on! PLUS was very encouraging. With more authorizations likely soon, a greater focus on enforcement, and the rejection of frivolous applications, a market can be created that rewards...
Filter
Filter
For much of the past decade, the US nicotine and ENDS marketplace has operated in a state of...
In 2025, Sweden achieved something virtually unheard of elsewhere: it became and may soon be...
3 minute read
The inaugural PouchEx 2025 conference, dedicated exclusively to nicotine pouches, was a niche event...
The 2025 Food and Drug Law Institute (FDLI) Tobacco and Nicotine Conference delivered something the...
6 minute read
When FDA deployed the “fatal flaw” concept during ENDS PMTA reviews, it was seen by many as a...
The 2025 CORESTA Product Science and Product Technology (PSPT) Conference brought together...
2 minute read
The 2025 Global Tobacco and Nicotine Forum (GTNF), held in Brussels, brought together policymakers,...
3 minute read
By Paul Hardman, Chemistry Consultant at Broughton With expert regulatory commentary from Lilian...
As the U.S. Food and Drug Administration’s Center for Tobacco Products (CTP) adjusts to a new era...
Ensure your business stays ahead of the competition by keeping up to date on the latest regulatory changes. Sign up for our newsletter to have the latest information and insights served directly to your inbox.